ACHV - Achieve +22% premarket after FDA meeting on cytisinicline development program December, 09 2019 06:13 AM Achieve Life Sciences Inc. Achieve Life Sciences (NASDAQ:ACHV) announces an update on the cytisinicline clinical development program.More news on: Achieve Life Sciences, Inc., Healthcare stocks news, Stocks on the move, Read more ...